TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Adalyon Appoints Ulrik Zeuthen as CEO to Drive Next Phase of Growth in AI-driven Speech-based Biomarkers and Behavioural Analytics for Optimising Clinical Trials

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Ulrik Zeuthen
Adalyon Appoints Ulrik Zeuthen as CEO to Drive Next Phase of Growth in AI-driven Speech-based Biomarkers and Behavioural Analytics for Optimising Clinical Trials

Adalyon, a tech-bio company specializing in AI-powered speech biomarkers for clinical trials, has appointed Ulrik Zeuthen as CEO. Zeuthen brings extensive pharmaceutical and data science experience to help transform clinical drug development through innovative speech analysis technology.

Insights
AMZN   positive

Part of the author's personal investment portfolio and recommended stock list


NVO   neutral

Mentioned as previous employer of new CEO, with no specific positive or negative context